COVID-19 and immune-mediated inflammatory diseases: Why don't our patients get worse?
作者信息
Martínez-Taboada Víctor M, López-Hoyos Marcos, Crespo Javier, Hernández José L
机构信息
Division of Rheumatology, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain; University of Cantabria, Santander, Spain.
Division of Immunology, Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
出版信息
Autoimmun Rev. 2020 Dec;19(12):102683. doi: 10.1016/j.autrev.2020.102683. Epub 2020 Oct 27.
Abstract
摘要
相似文献
1
COVID-19 and immune-mediated inflammatory diseases: Why don't our patients get worse?2019冠状病毒病与免疫介导的炎症性疾病：为何我们的患者病情没有恶化？
Autoimmun Rev. 2020 Dec;19(12):102683. doi: 10.1016/j.autrev.2020.102683. Epub 2020 Oct 27.
2
The immune roadmap for understanding multi-system inflammatory syndrome in children: opportunities and challenges.了解儿童多系统炎症综合征的免疫路线图：机遇与挑战
Nat Med. 2020 Dec;26(12):1819-1824. doi: 10.1038/s41591-020-1140-9.
3
When patients don't get the care they should.当患者没有得到他们应得的护理时。
J Fam Pract. 2020 Nov;69(9):427.
4
Myasthenia Gravis Associated With SARS-CoV-2 Infection.与严重急性呼吸综合征冠状病毒2型感染相关的重症肌无力
Ann Intern Med. 2020 Dec 15;173(12):1027-1028. doi: 10.7326/L20-0845. Epub 2020 Aug 10.
5
A new inflammatory-microthrombotic syndrome as an explanation for thrombotic complications in patients with COVID-19.一种新的炎症性微血栓形成综合征可解释新冠病毒疾病患者的血栓形成并发症
Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):115-116. doi: 10.1016/j.rec.2020.08.021. Epub 2020 Oct 2.
6
COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data.荷兰皮肤免疫介导疾病患者中的 COVID-19：真实世界观察数据。
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e173-e176. doi: 10.1111/jdv.17025. Epub 2020 Nov 22.
7
Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women?新型冠状病毒病 2019（SARS-CoV-2）与多囊卵巢病：这些女性的患病风险更高吗？
J Steroid Biochem Mol Biol. 2021 Jan;205:105770. doi: 10.1016/j.jsbmb.2020.105770. Epub 2020 Oct 13.
8
Association between myocardial injury and prognosis of COVID-19 hospitalized patients, with or without heart disease. CARDIOVID registry.新冠病毒疾病（COVID-19）住院患者（无论有无心脏病）心肌损伤与预后的关联。CARDIOVID注册研究。
Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):105-108. doi: 10.1016/j.rec.2020.08.005. Epub 2020 Aug 15.
9
Why does COVID-19 pathology have several clinical forms?为什么 COVID-19 病理学有几种临床形式？
Bioessays. 2020 Dec;42(12):e2000198. doi: 10.1002/bies.202000198. Epub 2020 Nov 11.
10
The Remote Misses of COVID-19.《COVID-19 的远程传播》。
Ann Intern Med. 2020 Dec 15;173(12):1010-1011. doi: 10.7326/M20-4984. Epub 2020 Aug 19.
引用本文的文献
1
Platelet-leukocyte crosstalk in COVID-19: How might the reciprocal links between thrombotic events and inflammatory state affect treatment strategies and disease prognosis?血小板-白细胞相互作用与 COVID-19：血栓事件和炎症状态之间的相互联系如何影响治疗策略和疾病预后？
Thromb Res. 2022 May;213:179-194. doi: 10.1016/j.thromres.2022.03.022. Epub 2022 Mar 31.
2
Rise and exacerbation of oral lichen planus in the background of SARS-CoV-2 infection.在 SARS-CoV-2 感染背景下口腔扁平苔藓的发作和加重。
Med Hypotheses. 2021 Nov;156:110681. doi: 10.1016/j.mehy.2021.110681. Epub 2021 Sep 20.
本文引用的文献
1
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.一组患有风湿性疾病的COVID-19患者的临床病程、严重程度和死亡率。
Ann Rheum Dis. 2020 Dec;79(12):1659-1661. doi: 10.1136/annrheumdis-2020-218054. Epub 2020 Jun 30.
2
Low frequency of COVID-19 in inflammatory bowel diseases.炎症性肠病中新冠病毒病的低发病率
Dig Liver Dis. 2020 Nov;52(11):1234-1235. doi: 10.1016/j.dld.2020.06.007. Epub 2020 Jun 13.
3
COVID-19 and psoriasis: biologic treatment and challenges.COVID-19 与银屑病：生物治疗及挑战
J Dermatolog Treat. 2022 Mar;33(2):699-703. doi: 10.1080/09546634.2020.1789051. Epub 2020 Jul 6.
4
Zero COVID-19 infection in inflammatory bowel disease patients: Findings from population-based inflammatory bowel disease registries in Hong Kong and Taiwan.香港和台湾基于人群的炎症性肠病登记处的数据：炎症性肠病患者中零 COVID-19 感染的发现。
J Gastroenterol Hepatol. 2021 Jan;36(1):171-173. doi: 10.1111/jgh.15164. Epub 2020 Jul 6.
5
Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors.西班牙一个由1037名接受生物制剂和JAK抑制剂治疗的风湿病患者组成的队列中重症新型冠状病毒肺炎的发病率。
Ann Rheum Dis. 2022 Jul;81(7):e131. doi: 10.1136/annrheumdis-2020-218152. Epub 2020 Jun 25.
6
Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic.COVID-19大流行期间大量类风湿性关节炎患者使用远程医疗的经验。
Ann Rheum Dis. 2021 May;80(5):e65. doi: 10.1136/annrheumdis-2020-218165. Epub 2020 Jun 25.
7
From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area.从美国震中地区看纽约大都市区炎症性肠病患者中的 2019 年冠状病毒病。
Inflamm Bowel Dis. 2021 Apr 15;27(5):662-666. doi: 10.1093/ibd/izaa162.
8
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.银屑病患者接受全身治疗或生物治疗不会增加患重症 COVID-19 的风险。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e676-e679. doi: 10.1111/jdv.16761. Epub 2020 Jul 9.
9
Covid-19 and autoimmunity.新冠病毒与自身免疫
Autoimmun Rev. 2020 Aug;19(8):102597. doi: 10.1016/j.autrev.2020.102597. Epub 2020 Jun 11.
10
Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.慢性炎症和自身免疫性风湿病患者中经医院聚合酶链反应（PCR）确诊的 COVID-19 病例的流行情况。
Ann Rheum Dis. 2020 Sep;79(9):1170-1173. doi: 10.1136/annrheumdis-2020-217763. Epub 2020 Jun 12.
Zotero 插件